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Abstract:  
Aim: The aim of this study was to evaluate the differences in ankle muscle strength using hand-held-
dynamometry and to assess difference in the isometric muscle force distribution between the people 
with diabetes and control participants. Methods: The maximal muscle strength of ankle 
plantarflexion, dorsiflexion, eversion, inversion, lesser toes flexors and extensors, hallux flexors and 
extensors was assessed in 20-people with diabetes and 20-healthy participants using hand-
helddynamometry. 
The maximal isometric ankle plantarflexion and dorsiflexion were imported to OpenSim software to 
calculate 12-individual muscle (8-plantarflexors and 4-dorsiflexors) forces acting on ankle joint. 
Results: A significant reduction in ankle strength for all measured actions and significant decrease in 
muscle force for each of the 12-muscles during dorsi and plantar flexion. Furthermore the ratios of 
agonist to antagonist muscle force for 6 of the muscles were significantly different between the 
healthy and people with diabetes. Conclusions: It is likely that the muscles for which the 
agonist/antagonist muscle force ratio were significantly different for the healthy and the people with 
diabetes, could be more affected by diabetes. 
 
 
 
 
 
Keywords: muscle force; diabetic; musculoskeletal model; biomechanics 
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1. Introduction 
 Type 2 diabetes (DM2) is accompanied by a wide range of impairments. Previous 
investigations have shown that DM2 is associated with a loss of mobility (Orr et al. 2006; 
Lalli et al. 2013) and reduced muscle strength (Andreassen et al. 2006). Several studies have 
also described impairment of gait (Brach et al. 2008; Raspovic, 2013), foot ulceration 
(Raspovic, 2013), and increased risk of falling (Lalli et al. 2013) in neuropathic diabetic 
patients. Furthermore, a reduced walking speed along with a compromised static and dynamic 
balance have also been observed in older diabetic patients with neuropathy (Lalli et al. 2013)). 
In addition, Andersen et al. (2004) showed that DM2 is associated with loss of muscle 
strength around the ankle and knee joint and Mueller et al. (1994) revealed that diabetic 
neuropathic patients were unable to generate sufficient ankle joint moment, with a consequent 
reduction in the dynamic function during walking, resulting in a smaller step length and 
stride, reducing gait speed and cadence. 
 Whilst,  neuropathy has been associated with impaired mobility, loss of muscle 
strength and decreased HR-QoL, as reviewed elsewhere (Van Schie, 2008), several factors 
could be responsible for this limited mobility and decreased muscle strength in diabetic 
patients; such as intrinsic abnormalities in diabetic muscle, impaired capillary recruitment, 
peripheralarterial disease and diabetic polyneuropathy (Andersen et al., 2004; Van Schie, 
2008, Lalli et al. 2013).  
 Although, most in vivo studies have analysed muscle performance under isokinetic 
conditions ( both active (Hatef et al., 2014) or passive (Hajrasouliha et al., 2005)), a simple, 
widely used and objective tool in a clinic for measuring muscle strength is hand-held-
dynamometer (Abizandaet al. 2012). Hand-held-dynamometers have been shown to be 
reliable for testing a number of muscle groups including those of the ankle (Wang et al., 2002; 
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Burns et al. 2005), but this device does not give any information about the individual muscle 
forces distribution. Since muscle forces cannot be measured invasively (Pandy, 2001), these 
quantities are determined using indirect methods combining kinematic and kinetics analysis. 
Muscle force distribution problem within biomechanics deals with the determination of the 
internal forces acting on the musculoskeletal system using the known resultant inter-
segmental forces and moments. The force distribution across human joints is typically 
represented with an indeterminate set of system equations; this means there are more 
unknowns than the number of equations that are most often used for calculating the muscle, 
ligament, and bone forces acting in and around joints. The analysis of muscle forces 
distribution is currently one of the major issues raised in biomechanics, requiring the use of 
sophisticated optimization models (Delp, et al., 2007). 
 There has been a paucity of studiesthat investigatethe individual muscle force 
distributions in people with diabetes. In light of the lack of such data, the aim of this 
pilotstudy was to evaluate differences in foot and ankle isometric muscle strength and to 
assess the difference in individual muscle force distributions between the people with diabetes 
and healthy controls. 
 
 
2. Material and Methods 
2.1. Participant recruitment and preparation 
 48 people with diabetes and severe neuropathy with a mean age of 59 ± 8.02 years, 
height of 1.66 ± 0.1 m and weight of 74.8 ± 7.23 kg participated in the study. Following a 
statistical analysis (detailed section 2.4.1) a subset of 20 of the 48 diabetic patients with mean 
age of 59 ± 9.84 years, height of 1.63 ± 0.1 m, weight of 71.6 ± 12.1 kg and average duration 
of diabetes 14 ± 7.8 years were selected for analysis. The diagnostic criteria for composing 
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the groups with signs and symptoms of neuropathy were based on the measurement of VPT at 
the Hallux, first, third or fifth metatarsals. The voltage was slowly increased at the rate of 1 
mV/sec and the VPT value was defined as the voltage level that produced a vibration that was 
sensed by the subject. The mean of the four records was calculated and neuropathy was 
diagnosed if the average was more than 25mV (Young et al, 1994). . Twenty healthy 
volunteers with mean age of 60.7 ± 7.5 years, height of 1.64 ± 0.6 m and weight of 73.2 ± 
6.12 kg were screened and included in the study. In both groups, the number of men and 
women were the same - 10 in each. A t-test was performed and showed no significant age 
differences between the healthy and diabetic group. The ethical approval was sought and 
granted by the local research ethics committee and all volunteers provided full informed 
consent. 
 
2.2. Instrumentation and data collection 
 Isometric muscle strength was measured using a Citec hand-held-dynamometer (CIT 
Technics, Haren, Netherlands). The manufacturer’s data state the device was factory 
calibrated to a sensitivity of 0.1% and a range of 0–500 N. The hand-held-dynamometer 
(HHD) measures the peak force produced by a muscle as it contracts while pushing against an 
object. A recent systematic review of HHD for assessment of muscle strength in the clinical 
setting found the instrument to be a reliable and valid tool (Stark et al., 2011). Isometric 
muscle strength was assessed using the ‘make test’, whereby the examiner held the HHD 
stationary while the participants actively exerted a maximal force. All tests were performed 
with the participants in a supine position with hips and knees extended and the lower limb 
stabilized proximal to the ankle joint as directed by (CIT Technics, Haren, Netherlands). The 
HHD was positioned against the lateral border of the foot distal to the base of the 5th 
metatarsal head to measure eversion; to the medial border of the foot, near the base of the 1st 
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metatarsal head to measure inversion; against the metatarsal heads on the plantar surface of 
the foot to measure plantarflexion, and on the dorsal aspect of the foot proximal to the 
metatarsal heads to measure dorsiflexion and over the interphalangeal joint of the hallux for 
hallux plantarflexion and dorsiflexion. For testing of the lesser digits, the dynamometer was 
placed on the plantar surface of the digits. Moreover, for testing both the hallux and lesser toe 
strength, the ankle was passively placed in maximum plantar flexion to prevent co-contraction 
of the ankle plantar flexor muscles influencing the result. 
 Each participant performed submaximal test movements for familiarization prior to 
testing. Testing of each muscle group required a contraction of 3-5 seconds. Three repetitions 
were obtained for each muscle group, for each leg with a minimum rest period of 10 seconds 
between each contraction. The average of the three contractions was used for analysis as mean 
values have been shown to be more reliable than maximal values (Van den Beld et al., 2006). 
Verbal encouragement was given during each contraction. To assess repeatability 
ofmeasurements, coefficients of variation (CVs) were calculated, which expresses between-
trial variability as a percentage. It has been suggested that CV values of 0.60 and greater 
indicate poor repeatability, 0.4–0.60 fair repeatability, 0.20 – 0.40 good repeatability and 0.20 
and less excellent repeatability (Krysicki et al., 2006). All measured with HHD parameters 
achieved good and excellent repeatability. 
2.3. Musculoskeletal model 
 A generic musculoskeletal model with 19 degrees-of-freedom and 92 musculo-tendon 
actuators was used to generate the simulation in OpenSim 2.4 (Stanford, USA) (Delp et al., 
2007). The model was dimensioned to represent a subject with a body mass of 72.6 kg. The 
feet of each subject were scaled to match the anthropometry, which was measured before the 
experiment. An inverse kinematics problem was solved to calculate the joint angles of the 
musculoskeletal model that the best reproduce the experimental kinematics of the subject, 
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what was distributed with OpenSim software. Following this step, individual muscle forces 
were computed using the computed muscle control (CMC) tool. CMC is an optimization 
based control technique designed specifically for controlling dynamic models that are 
actuated by redundant sets of actuators whose force generating properties may be nonlinear 
and governed by differential equations. The purpose of (CMC) is to compute a set of muscle 
excitations that will drive a dynamic musculoskeletal model to track a set of desired 
kinematics in the presence of applied external forces (Thelen et al., 2003). The OpenSim force 
data file was modified to allow simulations. For each subject plantarflexion force measured 
with HHD was put as a vertical force applied to toes as a body force and for each subject 
dorsiflexion force measured with HHD was applied as a vertical force with the same line as 
plantarflexion force but opposite direction also applied to toes as a body force. While the 
anterio-posterior and medio-lateral components of the ground reaction force are important 
during gait, in an isometric contraction we made sure that the measuring head of the 
dynamometer was held perpendicular to the plantar surface (in plantarflexion) and to the 
dorsal surface (in dorsiflexion). In this condition only the vertical component of the force 
causes a moment around the centre of rotation of the joint. Since the lever arm was 
perpendicular to the line of action of the force, hence the measured force by the dynamometer 
was the only component that exist during isometric dorsi and plantar flexion. For each person 
from the control and diabetic groups, muscle force distribution for each of the 12 muscles (8 
ankle plantarflexors: Flexor Digitorum, Flexor Hallucis, Gastrocnemius Lateral Head, 
Gastrocnemius Medial Head, Peronus Brevis, PeronusLongus, Soleus, Tibialis Posterior and 4 
ankle dorsiflexors: Extensor Digitorum, Extensor Hallucis, Peroneus Tertius, Tibialis 
Anterior) acting on the ankle joint were calculated. 
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2.4. Statistical analysis 
2.4.1. Outliers and Extremes 
 In order to achieve equinumerosity of the analysis groups (20 persons in each group) 
and in order to further simulation of muscle force distribution in the OpenSim software, the 
number of persons in the diabetes group was reduced. To do this the Statistica 8.0 software 
(StatSoft, PL) was used and analysis of outliers and extremes was applied. Analysis of 
outliers and extremes was applied for the following parameters: foot dorsiflexors, foot 
plantarflexors, foot inversion, foot eversion, lesser toes flexors, lesser toes extensors, hallux 
flexors, and hallux extensors which were measured using HHD device. Extreme values are the 
lowest and highest values in a given data set, while outliers are values that are significantly 
higher or lower than the remainder of the data. In order to be an outlier, the value must be:  
• larger than quartile 3 by at least 1.5 times the interquartile range, or 
• smaller than quartile 1 by at least 1.5 times the interquartile range (Aggarwal, 2013). 
All participants with extreme values at both ends were excluded from further analysis.  
 
2.4.2. Differences between groups 
 The ratio of agonist to antagonist (Ago/Ant) for each individual muscle was calculated 
in order to eliminate the fact that healthy persons applied more dorsiflexion and plantarflexion 
force using following formula: 
 
actionmusclexionplantarfleindividual
actionmusclexionplantarfleindividual
DFforF
PFforF
AntAgo /  or 
 
actionmuscleondorsiflexiindividual
actionmuscleondorsiflexiindividual
PFforF
DFforF
AntAgo /       (1) 
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 In order to assess the groups of dorsiflexion and plantarflexion muscles as a sum of 
individual muscle force contribution under applied plantarflexion and dorsiflexion measured 
force for both participants group the following ratios have been applied: 
 




8
1
8
1
n
actionPF
n
actionPF
DFforF
PFforF
RPF
n
n
    




4
1
4
1
n
actionDF
n
actionDF
PFforF
DFforF
RDF
n
n
  (2) 
 
where: 

8
1n
actionPF PFforF n  means the sum of forces of the eight individual plantarflexors 
when measured by HHD plantarflexion force was applied during simulation. The same 
explanation applies to the other components of the formula (1). 
 
 Normality of measured, simulated and calculated data distribution was assessed using 
the Shapiro-Wilk test. Non parametric U Mann–Whitney test was used to determine statistical 
significance between the diabetic and control group for all parameters. All data were analysed 
using Statistica 8.0 with the alpha level set at 0.05. 
 
 
3. Results 
3.1. Outliers and Extremes 
 An outlier and extreme are observations that lies an abnormal distance from other 
values in a random sample from a population. For all collected data for the diabetic group the 
box-and-whisker plots were completed in order to determine outliers and extremes points 
(Fig. 1). 
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Insert figure 1 here. 
 
 Through further analysis,people with more than two extremes were eliminated, which 
could be any combination of experimentally measured values. In the plantarflexion group 
values which were less than 90N and more than 190N were considered extremes. For the 
dorsiflexors group extreme values were below 70N and more than 170N. For inversion and 
lesser toes extensors group extreme values were below 50N and more than 110N. Similar 
condition was found for foot eversion and lesser toes flexors 60N and 120N. Extremes values 
for hallux flexorswere 60N and 130N, and for hallux extensors 40N and 90N. 
 
3.2. Healthy and diabetes comparison 
 The Shapiro-Wilk test indicated the measured and simulated datawas not normally 
distributed (P < 0.05). Thus, in order to determine statistical significance between the diabetic 
and control group for all parameters U Mann–Whitney test was used.  
 
Insert table 1 here. 
 
 Results presented in Table 1 demonstrated significant difference between diabetic and 
controls group for all of measured parameters. Moreover, all measured parameters values in 
the healthy control group were almost 1.5 times larger than in diabetic group. 
 
Insert table 2 here. 
 
 Results of simulation of individual muscle force distribution for plantarflexion and 
dorsiflexion acting force are presented in Table 2. Similar to the results from the HHD testing 
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we observed significant differences between diabetic and controls group for all of the 
individual muscle forces. Mean force for all muscles is almost 1.19 times higher for the 
control group during isometric plantarflexion and 1.11 during isometric dorsiflexion, when 
compared to the diabetic group. 
 Calculating the ratio of agonist to antagonistmuscles using formula (1), the fact that 
the healthy controls applied more force than the patients with diabetes (as measured by the 
HHD) was eliminated. For Ago/Ant radio we found that half the number of dorsiflexors 
(Extensor Digitorum, Tibialis Anterior) and half the number of plantarflexors muscle (Flexor 
Digitorum, Flexor Hallucis, Peronus Longus, Tibialis Posterior) shows no statistically 
significant difference (P > 0.05) between the group of healthy subjects and patients. 
 
Insert figure 2 here. 
 
 Formula (2) was applied in order to assess the groups of dorsiflexion and 
plantarflexion muscles as a sum of individual muscle force contribution under applied 
plantarflexion and dorsiflexion measured force for both participants groups. Figure 2 is a box-
and-whisker plot showing the median and interquartile ranges of ratios for control and 
diabetic group. Significant differences were found between the ratio calculated for control 
group during application of plantarflexion force and all other ratios for control and diabetic 
group (P = 0.00). Moreover, a significant difference was found between the ratio calculated 
for the control group during application of dorsiflexion force and the diabetic group during 
application of plantarflexion force (P = 0.01). 
 
 
4. Discussion 
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 The aim of this study was to evaluate differences in foot and ankle muscle strength 
between patients with diabetes and control participants using hand-held-dynamometry. The 
subsequent aim focused on the assessment of differences in individual muscle force 
distribution between the groups based on data from hand-held-dynamometry. This study has 
shown a significant reduction in plantarflexion, dorsiflexion, inversion and eversion, lesser 
toes flexors, lesser toes extensors, hallux flexors and hallux extensors muscle strength in 
patients with diabetes. Consequently it was also found that individual muscle force for each of 
the 12 muscles (8 ankle plantarflexors and 4 ankle dorsiflexors) acting on the ankle joint were 
significantly less in diabetic group in comparison to the control group.  
 Duration of diabetes and poor metabolic control are well-known risk factors for the 
development of muscle weakness (Andersen et al., 2004; Harbo et al., 2012). Weakness 
evaluated by manual testing has been reported to be an independent risk factor for the 
development of foot ulcers, probably because muscle weakness at the ankle and knee in 
diabetic neuropathy leads to abnormal application of pressure at the sole of the foot during 
walking (Andersenet al., 1996). The results of this study is in line with (Park et al., 2006) who 
reported that muscle quality, defined as muscle strength per unit regional muscle mass, was 
significantly lower in men and women with diabetes than those without diabetes in both upper 
and lower extremities. Andreassen et al. (2006) observed a certain worsening in muscle 
performance in patients with peripheral neuropathy. Ijzermanet al. ( 2012) examined patients 
with and without polyneuropathy. In both group patients leg muscle strength was reduced by 
30-50% compared to healthy subject. We found a lower reduction in muscle strength 
measured by HHD in our patients 28-37% compared to healthy. Giacomozzi et al.(2008) 
reported significant reduction of ankle mobility. They showed that dorsal-flexing torque were 
significantly reduced in all patients and in all foot positions, the highest reduction - 28% being 
for diabetes patients without neuropathy and 37% for patients withneuropathy. Since the 
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torque depends on both the force and the distance from the axis of rotation, and considering 
that for isometric conditions this distance has a constant value, we can see that our result show 
a 37% reduction for dorsiflexors and a 30% reduction for plantarflexors. In summary, results 
presented in Table 1 demonstrate that all values measured parameters by hand-held-
dynamometry including: plantarflexion, dorsiflexion, inversion and eversion, lesser toes 
flexors, lesser toes extensors, hallux flexors and hallux extensors in the healthy control group 
were almost 1.5 times larger than in diabetic group. 
 Actual estimates of muscle forces can only be obtained with computational models in 
which the skeleton and muscles are both represented. Implemented in a variety of forms, 
musculoskeletal models have been used in conjunction with non-invasive measurements to 
obtain individual muscle forces during a number of movement tasks. Until now, simulation of 
muscle force distribution was applied for measured kinematics and kinetics parameters during 
gait for healthy and disabled persons (Anderson and Pandy, 1999; Wang and Gutierrez-
Farewik, 2014). Within the current article, based on the data from a simple device which is 
the hand-held-dynamometer, individual muscle force could be estimated. Results for the 
simulation of individual muscle force distribution for plantarflexion and dorsiflexion acting 
force (Table 2) show a significant decrease in muscle force for each of the 12-muscles.  Mean 
force for all muscle is almost 16% lower for diabetes group during isometric plantarflexion 
action and 10% lower during isometric dorsiflexion action. We need to note that the current 
study examined the muscle force contribution of Diabetic neuropathic patients; hence the 
observed difference between the groups is attributed to the combined effect of neuropathy and 
diabetes. Giacomozzi et al (2008),when examining groups of diabetic and diabetic 
neuropathic patients against healthy participants, attributed the overall decrease in the ankle 
moment to muscle atrophy as a results of muscle tissue glycation and damage in addition the 
muscle atrophy as a result of impaired nerve conduction. These differences together with 
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alterations of cartilages, ligaments and tendons as a result of glycation (Worbel and Najafi, 
2010; Giacomozzi et al, 2005) could explain the deterioration in the muscle force contribution 
during isometric plantar and dorsi flexion contractions. Although the dynamometer is 
traditionally used for quantifying the agonists’ moment generating capacity, co-activation of 
antagonists can complicate interpretation of results essential for evaluating the effectiveness 
of a structured rehabilitation program. Co-activation of the antagonist during a contraction of 
the agonists results in a negative moment in relation to the moment developed by agonists, 
reducing the net resultant moment output. Very few studies have reported antagonistic co-
activation during agonistic maximal isometric contraction (Carolan and Cafarelli, 1992; 
Grabiner et al., 1992). In the current  paper the ratio agonist to antagonist (Equation 1) was 
calculated for each individual muscle force (Table 2). It was found that this ratio was 
statistically significant different (P < 0.05) between the healthy and diabetic group for two 
dorsiflexors (Peroneus Tertius, Extensor Hallucis) and four plantarflexors muscle 
(Gastrocnemius Medial Head, Gastrocnemius Lateral Head, Soleus, Peronus Brevis). These 
results have implications and relevance to the area of gait dysfunction in diabetic patients. 
Although Kwon and colleagues (2003) indicated that when compared to the healthy controls, 
patients with Diabetic neuropathy show more co-contractions of agonist and antagonist ankle 
muscles during the stance phase of gait. This agonist –antagonist co-contractions was deemed 
to facilitate a safer and more stable gait pattern to compensate for diminished foot sensation. 
For example, Hohne et al., (2012) reported an increased tibialis anterior and decreased 
gastrocnemius medialis muscle activity during foot flat to mid-stance phase of gait during a 
simulated sensory neuropathy using in tradermal anaesthetic injections. This decreased 
eccentric muscle activity of the gastrocnemius medial head during this phase of gait over time 
could lead to a decrease in muscle strength when the muscles act as agonist during maximum 
voluntary ankle plantar flexion.  
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 Based on this study the higher antagonist muscle force was expected since this group 
of muscles get activated as co – contractors during plantarflexion action. The antagonist 
muscle force for dorsiflexion action does not seem to reach the same magnitude as that of 
healthy individuals. On the other hand the fact that antagonist muscle force for plantarflexion 
muscle group in Diabetic patients is higher as compare to healthy controls can be attributed to 
neuropathy and to the fact that group of patients activate their plantarflexion muscles during 
dorsiflexion action to stabilize their joints. This may indeed be considered as the main reason 
for the observed increased antagonist muscle force for dorsiflexors group during isometric 
plantar flexion in diabetic patients as compared to healthy controls that is observed in the 
current study.  
 The results of this study could be further explained in the sense that Diabetic patients 
have learning effect and experience in activation dorsiflexion muscles as antagonist during 
stance phase of walking. Hence the Diabetic patients can effectively deactivate the antagonist 
muscle during isometric plantar flexion (dorsi flexor group) when there is no need for 
increasing balance or joint stiffness (i.e. when sitting and applying force to the dynamometer). 
On the other hand, Diabetic persons does not have experience of performing this task and 
with neuropathy and motor neural impairments they cannot deactivate these muscles. These 
individuals find deactivation antagonist plantar flexor muscles more challenging as compare 
to deactivating antagonist dorsi flexor muscles for which they train during stance phase of 
walking or in standing still. 
The ratio of the sum of agonist to the sum of antagonist muscle forces (Equation 2) during 
dorsi-flexion and plantar-flexion were significantly different in the healthy group, while this 
ratio for plantar-flexion was significantly different for the healthy group compared to the 
diabetic counterpart (Figure 1). 
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In summary, while the ankle muscle strength seem to be consistently and significantly 
different between the diabetic and healthy participants, the agonist/antagonist muscle force 
ratio seem to be only significantly different for half of the muscles involved in ankle 
plantar/dorsi-flexion actions. Because the central nervous system regulates the level of co-
contraction of agonist to antagonist muscles, it is likely that motor dysfunction as a result of 
diabetes and neuropathy may be more pronounced for the muscles for which the 
agonist/antagonist muscle force ratio were significantly different between the two groups. The 
ratio between agonist/antagonist muscle forces can be considered as a parameter showing the 
effectiveness of muscles in producing a high agonist isometric contraction and a low 
antagonist muscle contraction. While this ratio may be considered as a measure of neuro-
muscular capability of individual muscle, the results of this study have implications in 
quantifying this capacity in diabetic patients. 
 The results of this study are in line with Mueller et al. (1994) who revealed that 
diabetic neuropathic patients were unable to generate sufficient ankle joint moment, with a 
consequent reduction in the dynamic function during walking, resulting in a smaller step 
length and stride, reducing gait speed and cadence. In the present work it has been shown that 
the force of gastrocnemius-soleus muscle group as a strong ankle plantarflexors of diabetic 
patients is reduced by 30% compare to healthy subjects, under isometric plantarflexion. While 
the force of tibialis anterior, peroneus tertius, extensor digitorum and extensor hallucis was 
reduced by 26%, under isometric dorsiflexion force. The findings of this study can help in 
qualified prediction of each individual patient’s distal muscle strength. This information can 
then be used to design interventions at the early phase of the disease which could prevent the 
accelerated loss of strength and improve quality of life in these patients. 
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4.1 Limitation of our study 
 The identification of individual muscle contributions tobody support was possible 
through a detailed analysis of a computer simulation. Some limitations of musculoskeletal 
modeling and simulation generation and analysis have been described (Neptune et al., 2001; 
Zajac et al., 2002). Moreover in this paper, the CMC method was used based on ‘healthy’ 
model and it is documented in the literature (Orr et al. 2006; Andreassen et al. 2006; Lalli et 
al. 2013) important alterations in the muscle fibers histology and neurophysiology, as well in 
passive tissue properties in diabetic population. Therefore, using a healthy model to compute 
individual muscles force in diabetic individuals will definitely add some errors in the 
computation. But in the absence of the possibility to measure the individual muscles force, 
even estimation is good, in particular, when the report is presented first time in the literature. 
Therefore we believe that this is a challenge an open problem, but proposed in this paper 
research methodology applies only to static conditions, so this means that it can be used in the 
general diagnosis of the maximum muscle force loss in diabetics. 
 
5. Conclusions 
 This preliminarystudy adds to the limited amount of published information on foot and 
ankle muscle strength in patients with diabetes and increases the knowledge base on the 
individual muscle force distribution. The results indicate that patients with diabetes have 
reduced muscle strength in foot and ankle plantarflexion, dorsiflexion, eversion and inversion, 
lesser toes flexors, lesser toes extensors, hallux flexors and hallux extensors muscle strength. 
Consequently it was also found that muscle force for each of the 12 muscles (8 ankle 
plantarflexors and 4 ankle dorsiflexors) acting on the ankle joint were significantly less in the 
diabetic group in comparison to the control group. It is likely that the muscles for which the 
agonist/antagonist muscle force ratio were significantly different between the healthy and 
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diabetic groups, during ankle plantar/dorsi-flexion actionswere more affected by diabetes and 
may need more attention during rehabilitation programmers. Results from this study provide 
information for future research in this area. 
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Table 1 The mean and standard deviation (SD) for muscle strength testing measured with 
HHD, for diabetic and control group where: * indicates signiﬁcance at the P < 0.05 level for 
U Mann-Whitney test. 
 
Table 2 The mean and standard deviation (SD) for individual muscle force distribution for 
measured PF and DF action force and ratio agonist to antagonist (Ago/Ant) for diabetic and 
control group, where: * indicates signiﬁcance at the p <0.05 level for U Mann-Whitney test. 
 
Fig 1 Example of outliers and extremes for dorsiflexors data collected in group of 48 diabetic 
patients. 
 
Fig. 2 Box and whisker plots (median and interquartile range) for ratios (RDF and RPF) for 
control and diabetic group, where RDF, RPF - ratio of sum of agonist to sum of antagonist. 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
24 
 
 
 
 
 
 
Fig. 1 
 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
25 
 
 
 
 
 
 
 
 
 
 
Fig. 2 
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Table 1 The mean and standard deviation (SD) for muscle strength testing measured with 
HHD, for diabetic and control group where: * indicates signiﬁcance at the P < 0.05 level for 
U Mann-Whitney test. 
 
Movement 
Diabetic group  
mean (SD) 
Control group 
mean (SD) 
P - value 
Plantarflexion [N] 142.2 (27.87) 203.68 (32.7) 0.000* 
Dorsiflexion [N] 112.83 (24.75) 178.73 (27.41) 0.000* 
Inversion [N] 77.7 (16.42) 114.7 (26.69) 0.000* 
Eversion [N] 83.98 (13.15) 123.83 (25.88) 0.000* 
Lesser toes flexors [N] 90.08 (17.24) 128.65 (33.05) 0.000* 
Lesser toes extensors [N] 71.65 (13.1) 105.83 (27.8) 0.000* 
Hallux flexors [N] 97.1 (19.93) 140.65 (34.68) 0.000* 
Hallux extensors [N] 63.38 (10.6) 88.38 (28.54) 0.001* 
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Table 2 The mean and standard deviation (SD) for individual muscle force distribution for 
measured PF and DF action force and ratio agonist to antagonist (Ago/Ant) for diabetic and 
control group, where: * indicates signiﬁcance at the p < 0.05 level for U Mann-Whitney test. 
 
Diabetic group  
mean (SD) 
Control group  
mean (SD) 
P-value 
Individual 
muscle force 
PF 
action 
DF 
action 
Ago/ 
Ant 
PF 
action 
DF 
action 
Ago/ 
Ant 
PF 
action 
Diabetic 
vs. 
Control 
DF 
action 
Diabetic 
vs. 
Control 
Ago/Ant 
Diabetic 
vs. 
Control 
Gastrocnemius 
Medial Head 
[N] 
359.88 
(55.16) 
48.52 
(0.15) 
7.42 
(1.18) 
458.15 
(44.55) 
48.28 
(0.09) 
9.49 
(0.94) 
0.000* 0.000* 0.000* 
Gastrocnemius 
Lateral Head 
[N] 
64.71 
(10.98) 
23.29 
(3.51) 
2.84 
(0.6) 
84.34 
(8.9) 
22.4 
(0.04) 
3.77 
(0.4) 
0.000* 0.000* 0.000* 
Soleus [N] 
146.09 
(40.07) 
94.23 
(0.61) 
1.55 
(0.44) 
266.94 
(75.31) 
93.45 
(0.29) 
2.86 
(0.81) 
0.000* 0.000* 0.000* 
Tibialis 
Posterior [N] 
79.39 
(0.09) 
78.88 
(0.09) 
1.01 
(0) 
79.53 
(0.06) 
78.77 
(0.04) 
1.01 
(0) 
0.000* 0.000* 0.279 
Flexor 
Digitorum [N] 
9.29 
(0.01) 
9.24 
(0.01) 
1.01 
(0) 
9.31 
(0.01) 
9.23 
(0.00) 
1.01 
(0) 
0.000* 0.000* 0.417 
Flexor 
Hallucis [N] 
9.23 
(0.01) 
9.14 
(0.01) 
1.01 
(0) 
9.25 
(0.01) 
9.13 
(0.01) 
1.01 
(0) 
0.000* 0.000* 0.297 
Tibialis 
Anterior [N] 
172.17 
(22.46) 
421.71 
(56.3) 
2.46 
(0.21) 
223.84 
(27.75) 
569.32 
(60.1) 
2.55 
(0.19) 
0.000* 0.000* 0.085 
Peronus 
Brevis [N] 
15.56 
(0.01) 
15.49 
(0.01) 
1.01 
(0.01) 
15.58 
(0.01) 
15.47 
(0.01) 
1.01 
(0) 
0.000* 0.000* 0.030* 
Peronus 
Longus [N] 
35.91 
(0.03) 
35.74 
(0.03) 
1.01 
(0.01) 
35.95 
(0.02) 
35.7 
(0.01) 
1.01 
(0) 
0.000* 0.000* 0.058 
Peroneus 
Tertius [N] 
6.58 
(0.03) 
10.83 
(1.7) 
1.65 
(0.26) 
6.55 
(0.13) 
14.91 
(1.68) 
2.28 
(0.26) 
0.000* 0.000* 0.000* 
Extensor 
Digitorum [N] 
52.34 
(6.95) 
126.74 
(15.91) 
2.44 
(0.32) 
68.65 
(8.81) 
170.8 
(21.04) 
2.5 
(0.23) 
0.000* 0.000* 0.180 
Extensor 
Hallucis [N] 
5.38 
(0.47) 
13.3 
(1.68) 
2.47 
(0.27) 
6.78 
(0.86) 
17.84 
(2.08) 
2.64 
(0.22) 
0.000* 0.000* 0.025* 
 
 
